COMPARATIVE EVALUATION OF THE CLINICAL COURSE OF MEDICAL ABORTION WITH 200 AND 600 MG OF MIFEPRISTONE: PROSPECTIVE COHORT STUDY
- Autores: BELOKRINITSKAYA T.E.1, FROLOVA N.I.1, BELOKRINITSKAYA I.A.2, SUKHININA V.V.3
-
Afiliações:
- Chita State Medical Academy, Ministry of Health of the Russian Federation
- OOO Zdorovye Plyus (Health Plus) Medical Center
- Town Maternity Hospital
- Edição: Nº 3 (2014)
- Páginas: 81-86
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247198
- ID: 247198
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
Tatiana BELOKRINITSKAYA
Chita State Medical Academy, Ministry of Health of the Russian Federation
Email: tanbell24@mail.ru
MD, professor, Head of the Department of Obstetrics & Gynecology 672090, Russia, Chita, Gorkiy St. 39a
Nataly FROLOVA
Chita State Medical Academy, Ministry of Health of the Russian Federation
Email: taasyaа@mail.ru
Assistant of Professor, Department of Obstetrics & Gynecology 672090, Russia, Chita, Gorkiy St. 39a
Irina BELOKRINITSKAYA
OOO Zdorovye Plyus (Health Plus) Medical Center
Email: irinabelokrini@mail.ru
Director 672000, Russia, Chita, Chkalov's St. 136, Apt. 11
Victoria SUKHININA
Town Maternity Hospital
Email: tanbell24@mail.ru
the planning of a family doctor 672000, Russia, Chita, Shilov St. 47
Bibliografia
- Дикке Г.Б., Яроцкая Е.Л., Ерофеева Л.В. Стратегическая оценка политики, программ и услуг в сфере непланируемой беременности, абортов и контрацепции в Российской Федерации. Совместное исследование МЗ и СР РФ и ВОЗ. Проблемы репродукции. 2010; 3: 92-108.
- Безопасный аборт: Рекомендации для систем здравоохранения по вопросам политики и практики. Женева: Всемирная организация здравоохранения; 2004. 138 с.
- Радзинский В.Е. Акушерская агрессия. М.: Медиабюро Статус презенс; 2011. 688 с.
- WHO Library Cataloguing-in-Publication Data. Safe abortion: technical and policy guidance for health systems. 2nd ed. Geneva: World Health Organization; 2012. 123 p.
- Kulier R., Kapp N., Gülmezoglu A.M., Hofmeyr G.J., Cheng L., Campana A. Medical methods for first trimester abortion. Cochrane Database Syst. Rev. 2011; (1): CD002855.
- Urquhart D.R., Templeton A.A., Shinewi F., Chapman M., Hawkins K., McGarry J. et al. The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation; UK Multicentre Study - final results. Contraception. 1997; 55(1): 1-5.
- Белокриницкая Т.Е., Загородняя Э.Д., Лига В.Ф. Клинические протоколы оказания помощи в акушерстве и гинекологии. Часть
- Утверждены Министром Здравоохранения Забайкальского края 8.10.2012. Чита; 2012.
- World Health Organization Task Force on Postovulatory Methods for Fertility Regulation; Special Programme of Research, Development and Research Training. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br. J. Obstet. Gynaecol. 2000; 107(4): 524-30.
- El-Refaey H., Rajasekar D., Abdalla M., Calder L., Templeton A. Induction of abortion with mifepristone (Ru-486) and oral or vaginal misoprostol. N. Engl. J. Med. 1995; 332(15): 983-7.
- Fjerstad M., Trussed J., Sivin I., Lichtenberg E.S., Cullins V. Rates of serious infection after changes in regimens for medical abortion. N. Engl. J. Med. 2009; 361(2): 145-51.
- Tran N.T., Jang M.C., Choe Y.S., Ko W.S., Pyo H.S., Kim O.S. Feasibility, efficacy, safety and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People’s Republic of Korea. Int. J. Gynaecol. Obstet. 2010; 109(3): 209-12.
- Trussed J., Ellertson C. Estimating the efficacy of medical abortion. Contraception. 1999; 60: 119-35.
- Дикке Г.Б., Кутуева Ф.Р. Опыт прерывания беременности одной таблеткой мифепристона (200 мг) в комбинации с мизопростолом в амбулаторной практике женской консультации № 22 г. Санкт-Петербурга. Земский врач. 2012; 4: 25-30
- Boersma A.A., Meyboom-de Jong B., Kleiverda G. Mifepriston followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a genital practice in Curaçao. Eur. J. Contracept. Reprod. Health Care. 2011; 16(2): 61-6.
- Winikojf B., Dzuba I.G., Chong E., Goldberg A.B., Lichtenberg E.S., Ball C. et al. Extending outpatient medical abortion services through 70 days of gestational age. Obstet. Gynecol. 2012; 120(5): 1070-6.
- Moreno-Ruiz N.L., Borgatta L., Yanow S., Kapp N., Wiebe E.R., Winikoff B. Alternatives to mifepristone for early medical abortion. Int. J. Gynaecol. Obstet. 2007; 96(3): 212-8.
- Fiala Ch. Improving medical abortion. Using mifepristone in combination with a prostaglandin analog. Stockholm; 2005.
- Reeves M.F., Fox V.C., Lohr P.A., Creinin M.D. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet. Gynecol. 2009; 32: 104-9.
- Creinin M.D., Aubeny E. Medical abortion in early pregnancy. In: Paul M., Lichtenberg E.S., Borgatta L., Grimes D.A., Stubblefield P.G., eds. A clinician’s guide to medical and surgical abortion. New York: Churchill Livingstone; 1999: 91-106.
Arquivos suplementares
![](/img/style/loading.gif)